These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 10909781)
1. Corticosterone influences the NMDA receptor antagonist MK-801 induced hyperactivity in the rat. Healy DG; Kelly JP; Leonard BE Biochem Soc Trans; 1998 Feb; 26(1):S23. PubMed ID: 10909781 [No Abstract] [Full Text] [Related]
2. The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine. Hauber W; Andersen R Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):486-90. PubMed ID: 8114947 [TBL] [Abstract][Full Text] [Related]
3. Impact of metyrapone on MK-801-induced alterations in the rat dopamine D1 receptors. Czyrak A; Maćkowiak M; Fijał K; Chocyk A; Wedzony K Pol J Pharmacol; 1997; 49(5):305-16. PubMed ID: 9566029 [TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice. Dall'Igna OP; Da Silva AL; Dietrich MO; Hoffmann A; de Oliveira RV; Souza DO; Lara DR Psychopharmacology (Berl); 2003 Mar; 166(3):258-63. PubMed ID: 12589526 [TBL] [Abstract][Full Text] [Related]
5. The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade. Leriche L; Schwartz JC; Sokoloff P Neuropharmacology; 2003 Aug; 45(2):174-81. PubMed ID: 12842123 [TBL] [Abstract][Full Text] [Related]
6. Glycine and D-serine decrease MK-801-induced hyperactivity in mice. Nilsson M; Carlsson A; Carlsson ML J Neural Transm (Vienna); 1997; 104(11-12):1195-205. PubMed ID: 9503265 [TBL] [Abstract][Full Text] [Related]
7. Relationship between development of cross-sensitization to MK-801 and delayed increases in glutamate levels in the nucleus accumbens induced by a high dose of methamphetamine. Ito K; Abekawa T; Koyama T Psychopharmacology (Berl); 2006 Aug; 187(3):293-302. PubMed ID: 16850286 [TBL] [Abstract][Full Text] [Related]
8. Effect of the noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 on food-anticipatory activity rhythm in the rat. Ono M; Shibata S; Minamoto Y; Watanabe S Physiol Behav; 1996; 59(4-5):585-9. PubMed ID: 8778838 [TBL] [Abstract][Full Text] [Related]
9. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists. Hao JX; Xu XJ Pain; 1996 Aug; 66(2-3):279-85. PubMed ID: 8880851 [TBL] [Abstract][Full Text] [Related]
10. Nicotine and clozapine actions on pre-pulse inhibition deficits caused by N-methyl-D-aspartate (NMDA) glutamatergic receptor blockade. Levin ED; Petro A; Caldwell DP Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):581-6. PubMed ID: 15866361 [TBL] [Abstract][Full Text] [Related]
11. Effects of NMDA glutamate receptor antagonist drugs on the volitional consumption of ethanol by a genetic drinking rat. McMillen BA; Joyner PW; Parmar CA; Tyer WE; Williams HL Brain Res Bull; 2004 Sep; 64(3):279-84. PubMed ID: 15464866 [TBL] [Abstract][Full Text] [Related]
12. Spatial learning deficit after NMDA receptor blockade and state-dependency. Kretschmer BD; Fink S Behav Pharmacol; 1999 Jul; 10(4):423-8. PubMed ID: 10780810 [TBL] [Abstract][Full Text] [Related]
13. Characterization of MK-801-induced behavior as a putative rat model of psychosis. Andiné P; Widermark N; Axelsson R; Nyberg G; Olofsson U; Mårtensson E; Sandberg M J Pharmacol Exp Ther; 1999 Sep; 290(3):1393-408. PubMed ID: 10454519 [TBL] [Abstract][Full Text] [Related]
14. Influence of preemptive treatment with MK-801, an N-methyl-D-aspartate receptor antagonist, on development of neuropathic symptoms induced by spinal nerve ligation in the rat. Wei H; Pertovaara A Anesthesiology; 1999 Jul; 91(1):313-6. PubMed ID: 10422960 [No Abstract] [Full Text] [Related]
15. Differential efficacy of intrathecal NMDA receptor antagonists on inflammatory mechanical and thermal hyperalgesia in rats. Hama A; Woon Lee J; Sagen J Eur J Pharmacol; 2003 Jan; 459(1):49-58. PubMed ID: 12505533 [TBL] [Abstract][Full Text] [Related]
16. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat. Klamer D; Zhang J; Engel JA; Svensson L Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002 [TBL] [Abstract][Full Text] [Related]
17. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors. Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162 [TBL] [Abstract][Full Text] [Related]
18. Role of nitric oxide synthase inhibitors and NMDA receptor antagonist in nicotine-induced behavioral sensitization in the rat. Shim I; Kim HT; Kim YH; Chun BG; Hahm DH; Lee EH; Kim SE; Lee HJ Eur J Pharmacol; 2002 May; 443(1-3):119-24. PubMed ID: 12044801 [TBL] [Abstract][Full Text] [Related]